Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
March 24, 2020

[vc_row][vc_column][vc_single_image image="32187" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Cancer Research is Critical To Making Cures Possible. [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Find someone diagnosed with cancer, and they will have likely been treated with radiation therapy, chemotherapy, or by having the tumor surgically removed. Treatment is hardly enjoyable, but it is usually quite...

by
Blog
March 19, 2020

[vc_row][vc_column][vc_column_text] Researchers at the University of Cardiff discovered that MR1-restricted T-cells can be used to broaden both the types of cancer and patients that can be treated using cellular therapy. During the past decade, cancer immunotherapy has emerged, along with surgery, radiation, and chemotherapy, as a fourth,...

, ,

by
Blog, Press Release
March 12, 2020

FOR IMMEDIATE RELEASE: March 12, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A drug and drug delivery candidate technology, research into which has been funded by the National Foundation for Cancer Research (NFCR), has...

by
Blog, P4TC
March 5, 2020

Play4TheCure is dedicated to raising funds for the National Foundation for Cancer Research through competitive sports featuring recreational sports clubs, middle schools, high schools and collegiate sporting events. Through the program, teams are encouraged to brainstorm unique fundraising strategies. To help you get started on...

by
Blog, Press Release
February 28, 2020

Michael N. Hall, Ph.D., the National Foundation for Cancer Research’s (NFCR) 2017 Szent-Györgyi Prize for Progress in Cancer Research winner, and David Sabatini, M.D., Ph.D., were named winners of the 2020 Sjöberg Prize “for their discovery of the target of rapamycin and the mammalian target...